ANI launches authorized Lipofen generic

BAUDETTE, Minn. — ANI Pharmaceuticals on Monday launched its authorized generic of Lipofen (fenofibrate) capsules. The company had acquired the distribution rights to the medication earlier this year. 

 

The drug is indicated treat high LDL cholesterol, total cholesterol, triglycerides and apolipoprotein B in adults with primary hypercholesterolemia or mixed dyslipidemia, as well as treatment of adults with severe hypertriglyceridemia. The drug will be available in 50- and 150-mg dosage strengths. The authorized generic of Lipofen saw $21.9 million in sales in 2015, the company said.